Sodium zirconium cyclosilicate pretreatment for formula in vitro reduces potassium intake in infants with chronic kidney disease

二维码有效期 120s

作者 Liu Boxuan ^[1] Wang Teng ^[2] Chen Zhi ^[3] 学术成果认领

作者单位 Department of Internal Medicine, Beijing Fu Xing Hospital, Capital Medical University, Beijing 100069, China ^[1] CAIQTEST (Beijing) Co., Ltd., Beijing 100176, China ^[2] Department of Nephrology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing 100045, China ^[3]

栏目名称 Correspondence

DOI 10.1097/CM9.0000000000002461

发布时间 2025-03-04

浏览3
被引0
下载0

中华医学杂志英文版

2022年135卷24期

3007-3009页

SCIMEDLINEISTICCSCDCABP

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Sodium zirconium cyclosilicate pretreatment for formula in vitro reduces potassium intake in infants with chronic kidney disease

Sodium zirconium cyclosilicate pretreatment for formula in vitro reduces potassium intake in infants with chronic kidney disease

中华医学杂志英文版

相似文献

中华医学杂志英文版

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Sodium zirconium cyclosilicate pretreatment for formula in vitro reduces potassium intake in infants with chronic kidney disease

Sodium zirconium cyclosilicate pretreatment for formula in vitro reduces potassium intake in infants with chronic kidney disease

中华医学杂志英文版

相似文献

中华医学杂志英文版

相关期刊

检索历史清除